Back

The REBOARREST Trial, a randomized controlled trial on aortic occlusion during cardiac arrest

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Late Breaking Clinical Science: optimal management of cardiogenic shock Cardiac Arrest ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jostein Brede

St Olavs Hospital (Trondheim university hospital), Trondheim (Norway)

3 More presentations in this session

Presentation thumbnail
Age Analysis of the MCS in CS Meta Analysis
Professor U. Zeymer (Ludwigshafen, DE)
Slides Video
Presentation thumbnail
Long-term Outcomes of the DanGer Shock Trial
Professor J. Moller (Copenhagen, DK)
Slides Video
Presentation thumbnail
Centralization of CS care and MCS use
Doctor B. Schrage (Hamburg, DE)
Slides Video

Access the full session

Session thumbnail
Late Breaking Clinical Science: optimal management of cardiogenic shock
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Utilisation of a novel device for automated aortic balloon occlusion in refractory cardiac arrest
thumbnail
Congress Presentation
Optimal care post-return of spontaneous circulation: state of the art
thumbnail
Congress Presentation
Microaxial flow pump or standard care in infarct-related cardiogenic shock: the DanGer shock trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources